Sagamihara Public Health Center, 6-1-1 Fujimi, Chuo-ku, Sagamihara, Kanagawa 252-5277, Japan.
Environ Health Prev Med. 2013 Mar;18(2):165-70. doi: 10.1007/s12199-012-0289-3. Epub 2012 Jul 4.
Japanese public health policies on the prevention of atherosclerotic diseases have focused on controlling obesity. The aim of this study was to assess the prevalence of abnormality in risk factors for atherosclerotic disease among young Japanese classified according to body mass index (BMI).
Data were obtained from 359 men (mean age 32 ± 5 years) and 1,108 women (mean age 33 ± 4 years) between 2005 and 2010. Abnormal levels of aspartate aminotransferase, alanine aminotransferase, and/or gamma-glutamyltranspeptidase were considered to indicate liver dysfunction, and abnormal levels of low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and/or triglycerides were considered to indicate dyslipidemia. The cutoff points for high blood pressure (HBP) and hyperglycemia were set as a reference in the high-normal range.
No significant difference was observed in both sexes in all items among each year. In men, HBP (12.9 %), liver dysfunction (33.9 %), dyslipidemia (29.9 %), and hyperglycemia (2.7 %) were observed in the normal BMI group (18.5 < BMI ≤ 25 kg/m(2)). In women, these abnormalities were observed in both the normal BMI group and lean group.
Asymptomatic abnormalities, particularly liver dysfunction and dyslipidemia, were observed in a substantial percentage of subjects without obesity. Therefore, we recommend that the comprehensive public health policy should be directed at all individuals, including the non-obese group, for the early prevention/detection against atherosclerotic diseases.
日本预防动脉粥样硬化疾病的公共卫生政策一直侧重于控制肥胖。本研究旨在评估根据体重指数(BMI)分类的年轻日本人中动脉粥样硬化疾病风险因素异常的流行情况。
本研究数据来源于 2005 年至 2010 年期间的 359 名男性(平均年龄 32±5 岁)和 1108 名女性(平均年龄 33±4 岁)。天门冬氨酸氨基转移酶、丙氨酸氨基转移酶和/或γ-谷氨酰转肽酶异常水平被认为表示肝功能异常,而低密度脂蛋白胆固醇、高密度脂蛋白胆固醇和/或甘油三酯异常水平被认为表示血脂异常。高血压(HBP)和高血糖的临界点设定为高正常范围的参考值。
在每个年份,男女两性在所有项目中,正常 BMI 组(18.5<BMI≤25kg/m2)之间均无显著差异。在男性中,HBP(12.9%)、肝功能异常(33.9%)、血脂异常(29.9%)和高血糖(2.7%)见于正常 BMI 组。在女性中,这些异常见于正常 BMI 组和瘦体型组。
在没有肥胖的人群中,相当大比例的无症状异常,特别是肝功能异常和血脂异常,可能被忽视。因此,我们建议,针对动脉粥样硬化疾病的早期预防/检测,应将综合公共卫生政策指向所有人群,包括非肥胖人群。